International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism

被引：5

作者：

Tian, Mei ^{[1
,2
,3
,4
,5
]}

Zuo, Chuantao ^{[1
,2
,6
,7
]}

Cahid Civelek, A. ^{[8
]}

Carrio, Ignasi ^{[9
,10
]}

Watanabe, Yasuyoshi ^{[11
]}

Kang, Keon Wook ^{[12
]}

Murakami, Koji ^{[13
]}

Prior, John O. ^{[14
]}

Zhong, Yan ^{[3
,4
]}

Dou, Xiaofeng ^{[3
,4
]}

Yu, Congcong ^{[3
,4
]}

Jin, Chentao ^{[3
,4
]}

Zhou, Rui ^{[3
,4
]}

Liu, Fengtao ^{[6
,7
,15
]}

Li, Xinyi ^{[6
,7
,15
]}

Lu, Jiaying ^{[1
,2
,6
,7
]}

Zhang, Hong ^{[3
,4
,16
,17
,18
]}

Wang, Jian ^{[6
,7
,15
]}

机构：

[1] Fudan Univ, Huashan Hosp, Dept Nucl Med, Shanghai 200235, Peoples R China

[2] Fudan Univ, Huashan Hosp, PET Ctr, Shanghai 200235, Peoples R China

[3] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Nucl Med, 88 Jiefang Rd, Hangzhou 310009, Peoples R China

[4] Zhejiang Univ, Affiliated Hosp 2, PET Ctr, Sch Med, 88 Jiefang Rd, Hangzhou 310009, Peoples R China

[5] Fudan Univ, Human Phenome Inst, Shanghai 201203, Peoples R China

[6] Fudan Univ, Huashan Hosp, Natl Ctr Neurol Disorders, Shanghai 200040, Peoples R China

[7] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai 200040, Peoples R China

[8] Johns Hopkins Med, Dept Radiol & Radiol Sci, Div Nucl Med & Mol Imaging, Baltimore, MD 21287 USA

[9] Autonomous Univ Barcelona, Hosp Sant Pau, Res Inst, Barcelona 08025, Spain

[10] Autonomous Univ Barcelona, Hosp Sant Pau, Dept Nucl Med, Barcelona 08025, Spain

[11] RIKEN Ctr Biosyst Dynam Res, Lab Pathophysiol & Hlth Sci, Kobe, Hyogo 6500047, Japan

[12] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul 03080, South Korea

[13] Juntendo Univ Hosp, Dept Radiol, Tokyo 1138431, Japan

[14] Lausanne Univ Hosp, Dept Nucl Med & Mol Imaging, Lausanne, Switzerland

[15] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200235, Peoples R China

[16] Key Lab Med Mol Imaging Zhejiang Prov, Hangzhou 310009, Peoples R China

[17] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou 310007, Peoples R China

[18] Zhejiang Univ, Key Lab Biomed Engn, Minist Educ, Hangzhou 310007, Peoples R China

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷 / 02期

基金：

中国国家自然科学基金;

关键词：

Dopamine; Positron emission tomography (PET); Brain imaging; Parkinsonism; Expert consensus; DISEASE; PET; PROGRESSION; DEMENTIA; DIAGNOSIS; TRANSPORTERS; CRITERIA; TIME;

D O I：

10.1007/s00259-023-06403-0

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

PurposePresynaptic dopaminergic positron emission tomography (PET) imaging serves as an essential tool in diagnosing and differentiating patients with suspected parkinsonism, including idiopathic Parkinson's disease (PD) and other neurodegenerative and non-neurodegenerative diseases. The PET tracers most commonly used at the present time mainly target dopamine transporters (DAT), aromatic amino acid decarboxylase (AADC), and vesicular monoamine type 2 (VMAT2). However, established standards for the imaging procedure and interpretation of presynaptic dopaminergic PET imaging are still lacking. The goal of this international consensus is to help nuclear medicine practitioners procedurally perform presynaptic dopaminergic PET imaging.MethodA multidisciplinary task group formed by experts from various countries discussed and approved the consensus for presynaptic dopaminergic PET imaging in parkinsonism, focusing on standardized recommendations, procedures, interpretation, and reporting.ConclusionThis international consensus and practice guideline will help to promote the standardized use of presynaptic dopaminergic PET imaging in parkinsonism. It will become an international standard for this purpose in clinical practice.

引用

页码：434 / 442

页数：9

共 50 条

[41] Positron emission tomography molecular imaging for drug development
Matthews, Paul M.
Rabiner, Eugenii A.
Passchier, Jan
Gunn, Roger N.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (02) : 175 - 186
[42] Myocardial Perfusion Imaging Agents for Positron Emission Tomography
Mou Tiantian
Zhang Xianzhong
PROGRESS IN CHEMISTRY, 2012, 24 (10) : 1966 - 1973
[43] Imaging Tumor Metabolism Using Positron Emission Tomography
Lewis, David Y.
Soloviev, Dmitry
Brindle, Kevin M.
CANCER JOURNAL, 2015, 21 (02) : 129 - 136
[44] Radiotracers for positron emission tomography imaging
Nic Gillings
Magnetic Resonance Materials in Physics, Biology and Medicine, 2013, 26 : 149 - 158
[45] Positron Emission Tomography Imaging in Human Immunodeficiency Virus-1-Associated Neurocognitive Disorders An Interesting Case and a Review of the Positron Emission Tomography Literature
Meyer, Philipp T.
Gobbele, Rene
Ludolph, Alexander
Schaefer, Wolfgang M.
Waberski, Till-Dino
Schiel, Michael
CLINICAL NUCLEAR MEDICINE, 2009, 34 (08) : 496 - 499
[46] Clinical indications for Gallium-68 positron emission tomography imaging
Khan, M. U.
Khan, S.
Ei-Refaie, S.
Win, Z.
Rubello, D.
Al-Nahhas, A.
EJSO, 2009, 35 (06): : 561 - 567
[47] Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography
Tiihonen, J
Vilkman, H
Rasanen, P
Ryynanen, OP
Hakko, H
Bergman, J
Hamalainen, T
Laakso, A
Haaparanta-Solin, M
Solin, O
Kuoppamaki, M
Syvalahti, E
Hietala, J
MOLECULAR PSYCHIATRY, 1998, 3 (02) : 156 - 161
[48] Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography
J Tiihonen
H Vilkman
P Räsänen
O-P Ryynänen
H Hakko
J Bergman
T Hämäläinen
A Laakso
M Haaparanta-Solin
O Solin
M Kuoppamäki
E Syvälahti
J Hietala
Molecular Psychiatry, 1998, 3 : 156 - 161
[49] Clinical value of positron emission tomography (PET) in oncology: Results of an interdisciplinary consensus conference
Reske, SN
Bares, R
Bull, U
Guhlmann, A
Moser, E
Wannenmacher, MF
NUKLEARMEDIZIN, 1996, 35 (02) : 42 - 52
[50] The role of positron emission tomography imaging of β-amyloid in patients with Alzheimer's disease
Xiong, Kun-Lin
Yang, Qing-Wu
Gong, Shui-Gen
Zhang, Wei-Guo
NUCLEAR MEDICINE COMMUNICATIONS, 2010, 31 (01) : 4 - 11

← 1 2 3 4 5 →